PPD

We're feeling grateful for the insightful discussions and innovative presentations at #ACR24 in Washington, D.C. ?? When rheumatology comes together, it’s not just inspiring — it’s transformative. We're excited to see how new partnerships and projects will shape the future of the field!

?? Save the dates! We’re excited to return to San Francisco in the new year for the 43rd annual J.P. Morgan Healthcare Conference on Jan. 13-16. Let’s ensure your clinical development and funding strategies are aligned. ?? Email [email protected] to schedule a meeting with our team. #JPM2025 #JPM25

The Colorado chapter of our Community Action Councils (CACs) returned to Children's Hospital Colorado this year to knit blankets with patients and their siblings. Our colleagues are passionate about helping others and improving the communities where we live and work. Thermo Fisher Scientific fosters volunteer-led CACs at sites and regions around the world, resourcing colleagues to directly connect with local communities to provide rewarding volunteer opportunities and philanthropic support.

In this recent Drug Discovery & Development article, our patient #diversity experts explore strategies for how pharmaceutical and biotech companies can better empower and integrate sites with a track record of reaching #underserved communities to overcome well-documented diversity barriers.

What a night in RTP! We were honored to receive numerous recognitions at the 2024 PharmaTimes Clinical Researcher of the Year - The Americas competition. ?? Clinical Researcher Company of the Year ?????? Gold, silver and bronze individual and team awards for more than 25 of our colleagues ?? Read more ? https://bit.ly/4hZWtOk

Getting essential treatments to patients quickly and safely demands a comprehensive approach that reduces delay, complexity and risk throughout the drug development journey. Accelerator? Drug Development, Thermo Fisher Scientific's 360? CDMO and CRO solutions, brings all those necessary services under one roof, enabling customers to achieve their goals of getting treatments to patients faster. ?? Read more in our new blog. ? https://bit.ly/3Zdlv5h

In the constantly evolving and highly dynamic #biotech industry, there is intense pressure to remain flexible and agile enough to meet unexpected challenges and deliver programs on time and on budget. For biotech companies, who often lack in-house capabilities, resources and expertise, employing a functional service provider (FSP) model is a leading strategy for accessing the expertise and resource flexibility needed to meet their timelines. Check out our recent white paper to transform your biotech #FSP model and achieve your project goals. ??

We understand the challenges of developing new therapies for lupus, and we share your passion for finding better ways to improve treatment options for the estimated 5 million patients worldwide. >> https://bit.ly/47vQhJl

?? #ACR24: Stop by booth 2604 and meet our clinical trials experts at American College of Rheumatology (ACR) Convergence 2024, happening in Washington, D.C. This is the place “Where Rheumatology Meets” — uniting experts, innovators and leaders from around the globe. Whether you're looking to learn, collaborate or simply connect, we can’t wait to meet you! Let’s advance rheumatology together. #WhereRheumatologyMeets #clinicaltrials #rheumatology

?? #AHA24: We're excited to be at the heart of #cardiovascular clinical development in Chicago this weekend! Meet our experts (and enjoy a cookie! ??) at booth 1720.